Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC
Clinical trial NCT07554846 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07554846
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2030-05-01
- Enrollment
- 759
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.